2022: Successful transformation into a commercial stage comp

2022: Successful transformation into a commercial stage company


"2022 was a fantastic year for Calliditas as we launched TARPEYO® in the US, the first approved drug for... | February 23, 2023

Related Keywords

China , Sweden , Japan , United States , Stockholm , United Kingdom , Switzerland , Japanese , Chinese , American , Marie Galay , Kidney International , Viatris Pharmaceuticals Japan , Viatris Pharmaceuticals Japan Inc , European Commission , European Commission For Kinpeygo , American Society Of Nephrology , National Medical Products Administration , European Union Member States , American Society , Kidney Week , Everest Medicines , New Drug Application , Priority Review , China Everest Medicine , Events After , Reporting Period , Conditional Marketing Authorization , European Economic Area , Presentation February , Nasdaq Stockholm , American Depositary Shares , Nasdaq Global Select Market , Calliditas Therapeutics Ab Publ Stock Exchange , News , Information , Press Release , Uccessful , Transformation , Into , Commercial , Stage , Gas , Fantastic , Ear , Or , Calliditas , Us , The , Aunched , N , He , First , Approved , Rug Caltx Se0010441584 ,